Around three million people in the UK have kidney disease

example-header

Cardiovascular, metabolic and kidney disease: Cross-cutting science and best practice

Cardiovascular, metabolic and kidney disease: Cross-cutting science and best practice
at the Royal College of Physicians, London
Monday 1 July

Kidney Research UK, the Renal Association, NIHR and the Royal College of Physicians have jointly developed an exciting one-day conference taking place on 1 July at the Royal College of Physicians in London. aim is to stimulate discussion and ideas to address multi-morbidity and clustering of common diseases, whThe ich are major problems for health service providers.

Patients with kidney disease are at an increased risk of cardiovascular disease such as stroke, as well as diabetes and metabolic disease. The same is true in reverse. Several common mechanisms are thought to underpin disease in these different organ systems, yet the approach to treatment is often specialty specific. We therefore need greater integration of clinical and basic science research between these disease clusters, with shared treatments developed to address common pathways.

Speakers at this important event include experts from a broad range of related vascular and metabolic disease areas, including Steve Powis, the NHS Medical Director, Paul Elliott from the Medical Research Council (MRC) and representatives from the pharmaceutical industry.

Topics covered will look at:

  • the latest insights on the treatment of inflammation and fibrosis
  • how digital health, AI and imaging are driving research on delivering personalised medicine to patients – this includes a presentation on UKRIN-MAPS, a collaborative partnership with Kidney Research UK, funded initially by the MRC and supported by leading MRI manufacturers
  • the epidemiology of multimorbidity in vascular disease
  • data and biosample resources including the NURTuRE biorepository supported by Kidney Research UK, that can underpin our understanding and integrate future research in these specialties
  • broader multi -morbidity issues that impact on patients with long term conditions, such as psychiatry and mental health.

The conference will be of particular interest to clinicians, allied health professionals and scientists/researchers in nephrology, cardiology, diabetes, metabolic and endocrine and stroke medicine, specialists in ‘Omics’ research and scientists interested in regenerative medicine. Not-for-profit organisations can take advantage of a discounted registration fee of £150.00.

The full programme is available and registration is now open at RCP London.

Get our e-newsletter

Stay up to date with our kidney research news, events and ways to get involved.